Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same age their parents did.

Fortune

It's not just forgetfulness: 8 early warning signs of dementia

Nightmares and changes in vision can both be early warning signs of dementia.

Fortune

Inhaling this gas could help treat Alzheimer's disease, study suggests

A simple out-of-the-box treatment for Alzheimer's disease has been discovered by scientists which could help activate brain cells that assist in breaking down plaques and reducing inflammation associated with the neurodegenerative disease.

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

Thyroid, liver proteins help maintain brain health and help treat Alzheimer’s, study reveals

The recent study that links thyroid and liver proteins with brain functioning has promised a new approach to tackling Alzheimer’s disease. Certain thyroid and liver proteins have been discovered to be of high importance when it comes to moderation of the cognitive ability as well as providing protection against neurodegenerative…

The Times of India

Alzheimer’s may not be from amyloids

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease

Salon

Alzheimer's could be reversed, say researchers as study finds cellular mechanism behind it

A study published in the journal Neuron has found the cellular mechanism that links stress in the brain to the progression of Alzheimer's disease. This breakthrough can promise a major boost in the treatment of the disease.

The Times of India

Jobs That Save Lives? People In Certain Professions May Be At Reduced Risk Of Alzheimer's Death

Professions requiring constant navigation, such as taxi and ambulance drivers, might be at an advantage as a recent study found these workers have a reduced risk of death from Alzheimer's disease.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

New study will use phone apps to explore link between sleep and Alzheimer's risk

Cambridge University and UCL will collaborate with a tech company to explore how sleep tracking data can help detect Alzheimer's disease

Tom’s Guide

Study finds taxi and ambulance drivers less likely to die from Alzheimer's disease

A new study published in the British Medical Journal has revealed that deaths from Alzheimer’s disease are significantly lower among taxi and ambulance drivers, who frequently engage in processing spatial and navigational information. The findings suggest that these professions may offer a protective effect against Alzheimer’s, a progressive age-related condition…

The Times of India

These surprising professions have the lowest rate of Alzheimer’s disease deaths

Alzheimer’s disease is a form of dementia and it is one of the leading causes of death in the United States

The Independent UK

Does menopause hormone therapy increase or decrease your risk of dementia? Here’s the science

By 2050, around 135 million people worldwide will be living with dementia. The most common cause of dementia is Alzheimer’s disease. Women are more likely than men to develop Alzheimer’s disease, even after accounting for women living longer.

The Conversation

AI supercharged the sciences in 2024, revealing a major breakthrough in Alzheimer's diagnosis

A surge of AI-powered breakthroughs reminds us of the good that artificial intelligence can do, when placed in the right hands.

Laptop

Are you ignoring the early signs of Alzheimer's?

Brain fog and forgetfulness are common, but when these issues become more frequent or severe, they might be early signs of Alzheimer’s disease. In younger adults under 65, this is known as early-onset Alzheimer’s. Symptoms can include memory lapses, difficulty focusing, and confusion. For example, you may forget simple tasks…

The Times of India

How one health concern could predict Alzheimer’s disease decades before first symptoms occur

Alzheimer’s disease affects millions of Americans and is one of the top 10 causes of death in the U.S.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial

IGC Pharma, Inc.(NYSE:IGC) reported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents.

The Conversation

Vulnerability to financial scams in aging adults could be an early indicator of Alzheimer’s disease, new research shows

A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial exploitation. That is the key finding of our new study, published in the journal Cerebral Cortex.

Dynamite News

Study finds how Alzheimer's disease may damage brain in two phases

Alzheimer's disease may cause brain damage in two stages, according to new research supported by the National Institutes of Health (NIH) that uses sophisticated brain mapping methods. Read further on Dynamite News:

Evening Standard

Blood test could ‘reliably rule out’ Alzheimer’s, trial finds

There are hopes it will offer reassurance to patients with cognitive decline and help them avoid unnecessary further testing, researchers said.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

Kiplinger

Fell for a Financial Scam? Might Be Time to Test for Alzheimer's

Falling for financial scams may be an early indicator of Alzheimer's among older adults.

Inverse

Ozempic Outperformed 7 Diabetes Medications in Reducing the Risk for Alzheimer’s Disease

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 million patients with type 2 diabetes.

Evening Standard

Alzheimer's 'wonder drug' Donanemab blocked for use on NHS over cost concerns

Campaigners say decision is ‘frustrating setback’ for people living with disease

Evening Standard

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

Donanemab is a so-called disease-modifying treatment.

The Independent UK

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

Evening Standard

Donanemab – what we know about the latest Alzheimer’s drug

The drug is one of the new ‘disease modifying’ treatments for Alzheimer’s disease.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.